期刊文献+

PIK3CA在胃癌病变中表达的研究

The Expression of PIK3CA in Gastric Adenocarcinoma
下载PDF
导出
摘要 目的研究磷脂酰肌醇3-激酶催化亚基α(PIK3CA)表达与胃癌发病及不同病理级别胃肿瘤的关系,探讨其在胃癌发病中的作用机制。方法应用组织芯片技术结合免疫组化方法检测PIK3CA、丝氨酸/苏氨酸蛋白激酶(pAkt)、细胞增殖相关核抗原(ki-67)在胃腺癌、癌旁组织、正常胃黏膜中的表达情况,分析其与肿瘤发生的关系;进一步分析PIK3CA、pAkt、ki-67在不同胃癌病理级别组织中的表达情况,及其与肿瘤病理分级、分化的关系。结果 PIK3CA、pAkt、ki-67在胃癌组织中的表达显著增高(P<0.05),且在低分化胃腺癌中的表达最高(P<0.05),PIK3CA、pAkt和ki-67在不同病理级别胃癌及癌旁组织和正常胃黏膜组织中的表达两两之间呈正相关(P<0.05)。结论 PIK3CA可能作为磷脂酰肌醇3-激酶/蛋白激酶B(PI3K/Akt)信号通路的始动因子,促使Akt磷酸化,进而激活PI3K/Akt信号传导途径,促进胃癌增殖、侵袭与转移。 Objective To investigate the relationship between phosphatidylinositol 3-kinase catalytic subunit oL (PIK3CA) expression and the incidence and different pathological grade of gastric cancer, and the mechanism thereof. Meth- ods The expressions of PIK3CA, serine/threonine protein kinase (pAkt) and cell proliferation associated nuclear antigen (ki-67) in gastric carcinoma and adjacent tissues and normal gastric mucosa were detected by immunohistochemical method. The relationship between expressions of PIK3CA, pAkt and ki-67 and tumorigenesis was analyzed. The expressions of PIK3CA, pAkt and ki-67 in different pathological conditions of gastric tissues were analyzed. The relationship between tu- mor pathologic classification and differentiation were analyzed too. Results There were significantly higher expressions of PIK3CA, pAkt and ki,67 in gastric cancer (P 〈 0.05), which were the highest in the poorly differentiated gastric adenocarci- noma (P 〈 0.05). There were a positive correlation between expressions of PIK3CA, pAkt and ki-67 and different pathologi- cal levels of gastric carcinoma and adjacent tissues and normal gastric tissues (P 〈 0.05). Conclusion PIK3CA may be the initiating factor of PI3K/Akt signaling pathway, which induced phosphorylation of Akt and activation PI3K/Akt signaling pathway, promoting the proliferation, invasion and metastasis of gastric adenocarcinoma.
出处 《天津医药》 CAS 北大核心 2013年第11期1045-1047,I0001,共4页 Tianjin Medical Journal
基金 国家自然科学基金资助项目(项目编号:81172356) 天津市自然科学基金重点项目(项目编号:10JCZDJC18500) 天津市卫生局科技基金资助项目(项目编号:2010KY17)
关键词 胃肿瘤 腺癌 1-磷脂酰肌醇3-激酶 蛋白质丝氨酸苏氨酸激酶 KI-67抗原 免疫组织化学 组织芯片 stomach neoplasms adenocarcinoma 1-phosphatidylinositol 3-kinase protein-serine-threonine kinas-es ki-67 antigen immunohistochemistry tissue microarrays
  • 相关文献

参考文献2

二级参考文献75

  • 1Kang S, Bader AG, Zhao L, et al. Mutated PI 3-kinases: cancer targets on a silver platter. Cell Cycle, 2005,4:578-581.
  • 2Amzel LM, Huang CH, Mandelker D, et al. Structural comparisons of class I phosphoinositide 3-kinases. Nat Rev Cancer, 2008,8:665-669.
  • 3Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism, Nat Rev Genet, 2006,7:606-619.
  • 4Cantley LC. The phosphoinositide 3-kinase pathway. Science, 2002,296:1655 - 1657.
  • 5Katso R, Okkenhaug K, Ahmadi K, et al. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol, 2001,17: 615-675.
  • 6Samuels Y, Ericson K. Oncogenic PI3K and its role in cancer. Curt Opin Oncol, 2006,18:77-82.
  • 7Bachman KE, Argani P, Samuels Y, et al. The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther, 2004,3:772-775.
  • 8Campbell IG, Russell SE, Choong DY, et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res, 2004,64:7678 - 7681.
  • 9Karakas B, Bachman KE, Park BH. Mutation of the PIK3CA oncogene in human cancers. Br J Cancer, 2006,94:455-459.
  • 10Ligresti G, Militello L, Steelman LS, et al. PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches. Cell Cyete, 2009,8:1352-1358.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部